Tissue heterogeneity is commonly observed in clinical brachytherapy source implants. In some cases, an obvious variance in dose distribution will be caused by application of the AAPM recommended formulas, which are only valid for a homogeneous medium. By taking soft tissue as the base and considering adipose, air and bone as the separate interlayers, an evaluation model is established and dose correction formulas are derived for a single 125 I source in this study. The applicability of correction formulas is validated at different interlayer thicknesses and angles by Monte Carlo (MCNP 4C) simulations. The results show fairly good agreement between correction formulas and MC simulations with overall maximum variances of 1:62 AE 0:06, 5:93 AE 0:23, and 8:41 AE 0:33% for adipose, air, and bone, respectively.